510(k) Report

510(k) · Cleared

Cleared

Humapen and Humapen Ergo

K982842510(k) TraditionalCleared Sep 25, 199844-day reviewClass II21 CFR 880.5860

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Eli Lilly and Co. · FMF Syringe, Piston

Cleared on Sep 25, 1998 after a 44-day review. The FDA summary names its predicate without a number. 4 later devices descend from it.

Decided
Sep 25, 1998
Review
44 days
Class
Class II
Product code
FMF
Recalls
None
Predicates
0

4 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2007: 1 descendant cleared1999: 1 descendant cleared2009: 1 descendant cleared2008: 1 descendant cleared1995200020052010201520202025
  1. This deviceK982842 Humapen and Humapen ErgoEli Lilly and Co. · 1998
  2. Descendant · cites it directly · 2 of its ownK070100 Haselmeier PenHaselmeier Sarl · 2007
  3. Descendant · cites it directly · 0 of its ownK083457 TactipenHaselmeier GmbH · 2009
  4. Descendant · 2 generations on · 0 of its ownK082616 Haselmeier Pen 8Haselmeier GmbH · 2008
  5. Descendant · cites it directly · 0 of its ownK993666 Disetronic Pen P100Disetronic Medical Systems · 1999

Most influential descendants

Showing 4 of 4 · See all
  • K070100Haselmeier PenHaselmeier Sarl · 2007 · cites it directly2descendants
  • K083457TactipenHaselmeier GmbH · 2009 · cites it directly0descendants
  • K082616Haselmeier Pen 8Haselmeier GmbH · 2008 · 2 generations on0descendants
  • K993666Disetronic Pen P100Disetronic Medical Systems · 1999 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K982842Humapen and Humapen ErgoEli Lilly and Co.1998—
+1K070100Haselmeier PenHaselmeier Sarl2007—
+1K083457TactipenHaselmeier GmbH2009—
+2K082616Haselmeier Pen 8Haselmeier GmbH2008—
+1K993666Disetronic Pen P100Disetronic Medical Systems1999—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199910
200710
200810
200910
FIG. 1 — Lineage of K982842, 1998–2009Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FMF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FMF device

  1. #1 K241821 Luer Lock Syringe with Safety Needle; Luer…score 16.2 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—B-D Pen
Named without a submission number
—

What descends from it? (4)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K070100Haselmeier PenHaselmeier Sarl20072
K083457TactipenHaselmeier GmbH20090
K993666Disetronic Pen P100Disetronic Medical Systems19990

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K070100 (Haselmeier Sarl, 2007) has gone furthest, with 2 descendants of its own.

How does its category compare?

All FMF devices

FMF Syringe, Piston: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FMF

13in 2025

2007: 232008: 92009: 142010: 112011: 162012: 92013: 122014: 132015: 112016: 122017: 132018: 82019: 112020: 152021: 202022: 242023: 222024: 142025: 132026 (partial year): 9
2007high 24 (2022) · low 8 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FMF

114in 2025

2007: 90 days median2008: 74 days median2009: 94 days median2010: 130 days median2011: 109 days median2012: 86 days median2013: 154 days median2014: 84 days median2015: 87 days median2016: 146 days median2017: 135 days median2018: 87 days median2019: 146 days median2020: 107 days median2021: 175 days median2022: 211 days median2023: 173 days median2024: 130 days median2025: 114 days median2026 (partial year): 239 days median
2007high 239 (2026) · low 74 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FMF

19in 2023

2007: 62008: 112009: 152010: 122011: 32012: 62013: 12014: 12015: 22017: 32018: 22019: 12020: 22021: 12022: 22023: 19, 18 Class I2026 (partial year): 2, 1 Class I
2007high 19 (2023) · low 0 (2016)2026

Class I (19 since 2007) Class II/III not classified

Adverse event reports per year · FMF

4,181in 2025

2007: 6742008: 6912009: 9132010: 6792011: 1862012: 3072013: 3262014: 2442015: 2732016: 6842017: 1,8582018: 3,9522019: 5,8632020: 5,3342021: 5,8742022: 5,2332023: 5,2142024: 5,1222025: 4,181
2007high 5,874 (2021) · low 186 (2011)2025

MAUDE reports naming product code FMF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200723906674
200897411691
2009149415913
20101113012679
2011161093186
20129866307
2013121541326
201413841244
201511872273
2016121460684
20171313531,858
201888723,952
20191114615,863
20201510725,334
20212017515,874
20222421125,233
20232217319 (18)5,214
20241413005,122
20251311404,181
202692392 (1)—

What is it indicated for?

The HumaPen and the HumaPen Ergo are two versions of a reusable pen-injector

designed for use by diabetics for the self-injection of a desired dose of insulin. The pen-

injector uses 3.0 mL cartridges of insulin (Humalog® or Humulin®) and a single use,

detachable and disposable pen needle (supplied separately). The pen-injector allows the

user to dial the desired dose one unit at a time up to 60 units.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K982842: Humapen and Humapen Ergo.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K982842

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026